Neetha AlexKumar - Aroa Biosurgery General Counsel
| ARX Stock | 0.75 0.02 2.60% |
Executive
Neetha AlexKumar is General Counsel of Aroa Biosurgery
| Address | 64 Richard Pearse Drive, Auckland, New Zealand, 2022 |
| Phone | 64 9 869 3035 |
| Web | https://aroa.com |
Aroa Biosurgery Management Efficiency
The company has return on total asset (ROA) of (0.0586) % which means that it has lost $0.0586 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.108) %, meaning that it generated substantial loss on money invested by shareholders. Aroa Biosurgery's management efficiency ratios could be used to measure how well Aroa Biosurgery manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aroa Biosurgery's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 7.5 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 82.3 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robert Vilkaitis | Ras Technology Holdings | N/A | |
| Helen Cox | Macquarie Technology Group | N/A | |
| Angela Gunton | Ras Technology Holdings | N/A | |
| Roger MAusIMM | Centaurus Metals | N/A | |
| Anthony Sheard | Everest Metals | N/A | |
| Wayne Mausimm | Centaurus Metals | N/A | |
| Susan Scheepers | Aurelia Metals | N/A | |
| Michael Gold | Macquarie Technology Group | N/A | |
| Martin Cummings | Aurelia Metals | N/A | |
| Brent Dolan | Ras Technology Holdings | N/A | |
| MSc PMP | Centaurus Metals | 46 | |
| PMP MSc | Centaurus Metals | 45 | |
| Stephen Crispe | Ras Technology Holdings | N/A | |
| David Hirst | Macquarie Technology Group | N/A | |
| Simon Phillips | Everest Metals | N/A | |
| Luke Clifton | Macquarie Technology Group | N/A | |
| Angus Wyllie | Aurelia Metals | N/A | |
| Bahman Rashidi | Everest Metals | N/A | |
| BBus CA | Ras Technology Holdings | N/A | |
| Tim Olive | Ras Technology Holdings | N/A | |
| Justin Forsell | Macquarie Technology Group | N/A | |
Management Performance
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.0586 |
Aroa Biosurgery Leadership Team
Elected by the shareholders, the Aroa Biosurgery's board of directors comprises two types of representatives: Aroa Biosurgery inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aroa. The board's role is to monitor Aroa Biosurgery's management team and ensure that shareholders' interests are well served. Aroa Biosurgery's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aroa Biosurgery's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neetha AlexKumar, General Counsel | ||
| Frazer Murray, Director Strategy | ||
| Barnaby May, Chief Officer | ||
| Yasmin BSc, Regulatory Quality | ||
| Brian Ward, CEO, Founder | ||
| Adam Young, Vice Affairs | ||
| LLB BCom, CFO Secretary | ||
| MBA BVSc, CEO, Founder | ||
| Rod MSc, Chief Officer |
Aroa Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aroa Biosurgery a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.0586 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 243.16 M | ||||
| Shares Outstanding | 344.9 M | ||||
| Shares Owned By Insiders | 26.28 % | ||||
| Shares Owned By Institutions | 21.72 % | ||||
| Price To Book | 3.04 X | ||||
| Price To Sales | 3.75 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aroa Stock Analysis
When running Aroa Biosurgery's price analysis, check to measure Aroa Biosurgery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aroa Biosurgery is operating at the current time. Most of Aroa Biosurgery's value examination focuses on studying past and present price action to predict the probability of Aroa Biosurgery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aroa Biosurgery's price. Additionally, you may evaluate how the addition of Aroa Biosurgery to your portfolios can decrease your overall portfolio volatility.